{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:06:55Z","timestamp":1791094015350,"version":"4.1.0"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T00:00:00Z","timestamp":1374624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2013,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>hildren's <jats:styled-content style=\"fixed-case\">O<\/jats:styled-content>ncology <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>roup's A5971 trial examined central nervous system (<jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>) prophylaxis and early intensification in paediatric patients diagnosed with <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>\u2010negative Stage <jats:styled-content style=\"fixed-case\">III<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">IV<\/jats:styled-content> lymphoblastic lymphoma. Using a 2\u00a0\u00d7\u00a02 factorial design, the study randomized patients to <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>hildren's <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>ancer <jats:styled-content style=\"fixed-case\">G<\/jats:styled-content>roup (<jats:styled-content style=\"fixed-case\">CCG<\/jats:styled-content>) modified Berlin\u2010Frankfurt\u2010Muenster (<jats:styled-content style=\"fixed-case\">BFM<\/jats:styled-content>) acute lymphoblastic leukaemia (<jats:styled-content style=\"fixed-case\">ALL<\/jats:styled-content>) regimen with intensified intrathecal (<jats:styled-content style=\"fixed-case\">IT<\/jats:styled-content>) methotrexate (<jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>) (Arm A1) or an adapted non\u2010Hodgkin lymphoma\/<jats:styled-content style=\"fixed-case\">BFM<\/jats:styled-content>\u201095 therapy with high dose <jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content> in interim maintenance but no <jats:styled-content style=\"fixed-case\">IT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content> in maintenance (Arm B1)<jats:bold>.<\/jats:bold> Each cohort was randomized \u00b1 intensification (cyclophosphamide\/anthracycline) (Arms A2\/B2). For the 254 randomized patients, there was no difference in 5\u2010year event\u2010free survival (<jats:styled-content style=\"fixed-case\">EFS<\/jats:styled-content>) for the four arms: Arm A1<jats:bold>,<\/jats:bold> 80% [95% confidence interval (<jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>) 67\u201389%] and Arm A2<jats:bold>,<\/jats:bold> 81% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 69\u201389%); Arm B1<jats:bold>,<\/jats:bold> 80% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 68\u201388%) and Arm B2<jats:bold>,<\/jats:bold> 84% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 72\u201391%). The cumulative incidence of <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content> relapse was 1\u00b72%. Age &lt;10\u00a0years and institutional imaging response at 2\u00a0weeks was associated with improved outcomes (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001 and <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7014 for overall survival). <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content> positive patients (<jats:italic>n<\/jats:italic>\u00a0=\u00a012) did poorly [5\u2010year <jats:styled-content style=\"fixed-case\">EFS<\/jats:styled-content> of 63% (95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> 29\u201385%)]. For <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content>\u2010negative patients, there was no difference in outcome based on <jats:styled-content style=\"fixed-case\">CNS<\/jats:styled-content> prophylaxis (<jats:styled-content style=\"fixed-case\">IT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">MTX <\/jats:styled-content><jats:italic>versus <\/jats:italic><jats:styled-content style=\"fixed-case\">HD<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">MTX<\/jats:styled-content>) or with intensification.<\/jats:p>","DOI":"10.1111\/bjh.12460","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T21:13:36Z","timestamp":1374700416000},"page":"792-801","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Disseminated lymphoblastic lymphoma in children and adolescents: results of the <scp>COG A<\/scp>5971 trial: a report from the <scp>C<\/scp>hildren's <scp>O<\/scp>ncology <scp>G<\/scp>roup"],"prefix":"10.1111","volume":"162","author":[{"given":"Amanda M.","family":"Termuhlen","sequence":"first","affiliation":[{"name":"Department of Pediatrics Keck School of Medicine University of Southern California Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette M.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Biostatistics University of Nebraska Medical Center Omaha NE USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie L.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Department of Pathology and ARUP Laboratories University of Utah Health Sciences Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lones","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine University of California Los Angeles Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Finlay","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Keck School of Medicine Children's Hospital of Los Angeles University of Southern California Los Angeles CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Harvard Medical School Massachusetts General Hospital for Children Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Gross","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Nationwide Children's Hospital The Ohio State University College of Medicine Columbus OH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minnie","family":"Abromowitch","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Children's Hospital and Medical Center of Omaha University of Nebraska Omaha NE USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,7,24]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07320.x"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198303103081003"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.6.1024"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-132837"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05735.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.2707"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.3367"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.7661"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.1318"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-09-114082"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-10-247965"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08541.x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.09.009"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950180403"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.11.2234"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2006.07.011"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11615"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.920"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/1096-911X(200007)35:1<20::AID-MPO4>3.0.CO;2-L"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07607.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22162"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20550"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.2.359"},{"key":"e_1_2_8_25_1","first-page":"416","article-title":"Intensive ALL\u2010type therapy without local radiotherapy provides a 90% event\u2010free survival for children with T\u2010cell lymphoblastic lymphoma: a BFM group report","volume":"95","author":"Reiter A.","year":"2000","journal-title":"Blood"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-200302000-00005"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.0700"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605093341906"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.400"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-070342"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.405"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.2.389"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.6.1368"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.02.011"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1102160"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjh.12460","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjh.12460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:16:58Z","timestamp":1696324618000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bjh.12460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,24]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["10.1111\/bjh.12460"],"URL":"https:\/\/doi.org\/10.1111\/bjh.12460","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,24]]},"assertion":[{"value":"2013-03-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-06-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-07-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}